We Give Shareholders a Voice
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Itamar Medical Ltd. (NASDAQ: ITMR) (“Itamar” of the “Company”) with ZOLL Medical Corporation. (“ZOLL Medical”). Under the terms of the merger, ZOLL Medical will acquire all outstanding ordinary shares of Itamar Medical for $31 per American Depository Share (ADS), or $1.03 (equivalent to approximately NIS 3.31) per ordinary share, in cash.
The Itamar merger investigation concerns whether the Board of Itamar has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.
To receive more information, please fill out the form.